This overview page provides a quick summary of the selected assets, including their latest prices, price changes, market capitalization changes, and more.
This page just gave you an overview, you might also want to check out the comprehensive stats, historical, correlation, volatility, and price projection pages.
This security represents a warrant, giving the holder the right to purchase shares of the underlying company at a specified price before a certain expiration date. The underlying company, Kura Oncology, Inc., is a clinical-stage biopharmaceutical company focused on developing and commercializing precision medicines for the treatment of cancer. Kura Oncology's pipeline centers on small molecule inhibitors targeting key pathways involved in cancer cell growth and survival. Their lead drug candidate, tipifarnib, is being investigated for various hematologic malignancies and solid tumors, particularly those with specific genetic mutations. The company operates within the biotechnology and pharmaceutical industry, a sector characterized by extensive research and development, rigorous clinical trials, and significant regulatory oversight. Kura Oncology aims to establish a strong market position by advancing novel therapies that address unmet medical needs in oncology.
Read moreThis website uses cookies for essential functions, other functions, and for statistical purposes. Please refer to the cookie policy for details.
This feature requires functional cookies. Please refer to the cookie policy for details.
We sent you a verification email. Copy and paste the verification code above.
Trade hundreds of crypto perpetual futures